Grant: Discovery Grants Program - Individual
The University of Western Ontario
$28,000.00
Cell polarity and embryonic heart development
FY 2024-25
Summary
The heart is the first organ to function in all vertebrates, and is developed from three distinct populations of cells: the first heart field, the second heart field (SHF) and the cardiac neural crest. Heart development is regulated by a cascade of interacting transcription factors, including Nkx2.5, Gata4, Tbx5 and Mef2c. Notably, Nkx2.5, a member of the NK homeobox gene family, is one of the earliest cardiomyocyte specific markers in vertebrate embryos.
Coronary arteries are mainly developed from several progenitor sources including the proepicardial organ (PEO) and the epicardium with contributions from the endothelial cells of sinus venosus and the endocardium. Initially, cells from the PEO migrate toward the myocardium and form the epicardium. A subset of epicardial cells undergo epithelial-to-mesenchymal transition (EMT), migrate to the myocardium and give rise to vascular smooth muscle cells and fibroblasts while subepicardial endothelial progenitors give rise to coronary endothelial cells. A transcription factor critical to epicardial EMT and coronary vasculogenesis is Wilms tumour-1 (Wt1).
Cell polarity refers to spatial asymmetries in the shape, orientation or structure of cells, and includes apical-basal, front-rear and planar polarity. Rac1, a member of the Rac small GTPase family, regulates many cellular processes including cell polarity. We recently demonstrated that SHF specific deletion of Rac1 results in aberrant progenitor cellular organization, impairment of cardiomyocyte elongation, and malformation of outflow tract and the cardiac septum. The goal of the present proposal is to study cardiomyocyte and epicardial specific roles for Rac1 in heart organogenesis and coronary vasculogenesis in mice.
Hypothesis: Rac1 is critical to both myocardial and coronary artery development. Targeted disruption of Rac1 expression in each of these lineages will give rise to distinct heart and coronary artery malformations.
Aim 1 will study the role of Rac1 in cardiomyocyte polarity and heart development. Aim 2 will investigate the role of Rac1 in epicardial polarity, EMT and coronary vasculogenesis. Heart morphogenesis and coronary artery formation will be studied using genetically modified mouse models. Molecular and cellular techniques will be employed to shed light on the underlying mechanisms. The proposed studies will provide new insight on the role of Rac1 in cell polarity, EMT and heart/coronary morphogenesis during embryonic heart development.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2017-06581
Name nom
Feng, Qingping
Department département
Physiology and Pharmacology
Organization id
36
Institution établissement
The University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2017
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5509
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal morphology
Research subject fr
Morphologie animale
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Cell polarity and embryonic heart development
Keywords
cell polarity; embryonic heart development; mouse
Application summary
The heart is the first organ to function in all vertebrates, and is developed from three distinct populations of cells: the first heart field, the second heart field (SHF) and the cardiac neural crest. Heart development is regulated by a cascade of interacting transcription factors, including Nkx2.5, Gata4, Tbx5 and Mef2c. Notably, Nkx2.5, a member of the NK homeobox gene family, is one of the earliest cardiomyocyte specific markers in vertebrate embryos.
Coronary arteries are mainly developed from several progenitor sources including the proepicardial organ (PEO) and the epicardium with contributions from the endothelial cells of sinus venosus and the endocardium. Initially, cells from the PEO migrate toward the myocardium and form the epicardium. A subset of epicardial cells undergo epithelial-to-mesenchymal transition (EMT), migrate to the myocardium and give rise to vascular smooth muscle cells and fibroblasts while subepicardial endothelial progenitors give rise to coronary endothelial cells. A transcription factor critical to epicardial EMT and coronary vasculogenesis is Wilms tumour-1 (Wt1).
Cell polarity refers to spatial asymmetries in the shape, orientation or structure of cells, and includes apical-basal, front-rear and planar polarity. Rac1, a member of the Rac small GTPase family, regulates many cellular processes including cell polarity. We recently demonstrated that SHF specific deletion of Rac1 results in aberrant progenitor cellular organization, impairment of cardiomyocyte elongation, and malformation of outflow tract and the cardiac septum. The goal of the present proposal is to study cardiomyocyte and epicardial specific roles for Rac1 in heart organogenesis and coronary vasculogenesis in mice.
Hypothesis: Rac1 is critical to both myocardial and coronary artery development. Targeted disruption of Rac1 expression in each of these lineages will give rise to distinct heart and coronary artery malformations.
Aim 1 will study the role of Rac1 in cardiomyocyte polarity and heart development. Aim 2 will investigate the role of Rac1 in epicardial polarity, EMT and coronary vasculogenesis. Heart morphogenesis and coronary artery formation will be studied using genetically modified mouse models. Molecular and cellular techniques will be employed to shed light on the underlying mechanisms. The proposed studies will provide new insight on the role of Rac1 in cell polarity, EMT and heart/coronary morphogenesis during embryonic heart development.